Delivery Order SPE2DB22D2206-SPE2DB25FJL04
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Benlysta 200 mg/mL syringes valued at $6,152.80, with completion targeted for September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement supporting federal medical supply requirements. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Benlysta 200 mg/mL auto-injector with a ceiling value of $3,082.67. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by August 18, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with the company serving as the prime contractor on this delivery...
- The Defense Logistics Agency awarded a delivery order contract valued at $6,165.34 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector on July 24, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no...
- The Defense Logistics Agency awarded a $3,082.67 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Benlysta 200 mg/ml auto-injector units. This is a firm fixed price contract with an ultimate completion date of August 14, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Benlysta 200 mg/ml syringes valued at $3,076.40. This is a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a non-competitive set-aside. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector, with a ceiling value of $3,082.67. The contract was awarded on July 30, 2025, with an ultimate completion date of August 20, 2025, and utilizes firm fixed-price pricing under a non-competitive, non-set-aside arrangement. Performance will be executed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $3,082.67 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Benlysta 200 mg/mL auto-injector medications. This contract, which is a child award under an existing vehicle, carries an ultimate completion date of September 8, 2025, and involves no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 25, 2025, for the supply of Benlysta 400 mg vials, with a ceiling value of $13,678.56 and firm fixed pricing. The contract is non-set-aside and competitively awarded, with an ultimate completion date of August 15, 2025. Performance will be executed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $6,165.34 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. This firm fixed price, non-set-aside contract was executed on August 18, 2025, with an ultimate completion date of September 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $9,248.01 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/mL auto-injectors. This firm fixed-price contract, awarded on July 28, 2025, with completion targeted for August 18, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation. AmerisourceBergen, headquartered in...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJL04Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Benlysta 200 mg/mL syringes, with a ceiling value of $12,305.60. This is a firm fixed price delivery order with an ultimate completion date of September 5, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor critical to federal medical procurement, particularly for military and veteran healthcare systems. This delivery order falls under AmerisourceBergen's prime indefinite delivery vehicle with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and running through December 2026. The prime IDV functions as a comprehensive global pharmaceutical support contract enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Benlysta, a lupus treatment medication, represents one of the specialty pharmaceutical products delivered through this vehicle to support Defense Health Agency requirements and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 8/14/25 |